Both in Pharmaceuticals
BeOne Medicines vs Amarin
Over the past year ONC returned +23.6% and AMRN returned −26.8%; their daily moves had a correlation of 0.08.
ONC +23.6% AMRN −26.8%Growth of $1, one year, split-adjusted
| Metric | ONC | AMRN |
|---|---|---|
| Price | $406.96 | $11.61 |
| Market cap | $46.49B | $488.1M |
| Today | +5.09% | +0.30% |
| 1 month | +16.2% | −3.2% |
| 6 months | +30.4% | −22.9% |
| Year to date | +34.0% | −16.8% |
| 1 year | +26.6% | −24.2% |
| Revenue growth (YoY) | +29.6% | −20.4% |
| Gross margin | 89.8% | 40.9% |
| Net margin | 13.9% | 0.6% |
| P/E (TTM) | 70.9× | — |
| Price / sales | 7.6× | 2.8× |
| Net cash | $4.02B | $323.4M |
| Dividend yield | — | — |
| Volatility (60d) | 33.3% | 31.0% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).